Skip to main content
    D

    Doximity Inc (DOCS)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $31.50
    +1.57 (+5.26%)

    Market Cap: $5.45B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(19/21)
    Avg Surprise
    +30.88%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.35
    Range$0.32 - $0.40
    18 analysts
    EPS RevisionsNo revisions (7d)
    2
    13
    30d
    EPS Estimate DriftChange to current
    90d ago$0.37-6.1%
    60d ago$0.35-0.6%
    30d ago$0.35+0.3%
    7d ago$0.35+0.3%
    Current$0.35
    Revenue Consensus
    $171M
    Range$170M - $177M
    19 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.42
    Range$0.37 - $0.49
    18 analysts
    EPS RevisionsNo revisions (7d)
    3
    13
    30d
    EPS Estimate DriftChange to current
    90d ago$0.44-5.8%
    60d ago$0.42-0.8%
    30d ago$0.42+0.3%
    7d ago$0.42+0.3%
    Current$0.42
    Revenue Consensus
    $195M
    Range$189M - $201M
    19 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$0.28---
    Dec 26EST
    		-$0.42---
    Sep 26EST
    		-$0.35---
    Jun 26
    Reported Aug 6
    		$0.14$0.16-12.50%Miss-48.1%
    Mar 26
    Reported May 13
    		$0.26$0.28-7.14%Miss-18.8%
    Dec 25
    Reported Feb 5
    		$0.46$0.45+2.22%Beat+2.2%
    Sep 25
    Reported Nov 6
    		$0.45$0.38+18.42%Beat+50.0%
    Jun 25
    Reported Aug 7
    		$0.27$0.24+12.50%Beat-3.6%
    Mar 25
    Reported May 15
    		$0.32$0.20+60.00%Beat+28.0%
    Dec 24
    Reported Feb 6
    		$0.45$0.34+32.35%Beat+55.2%
    Sep 24
    Reported Nov 7
    		$0.30$0.26+15.38%Beat+36.4%
    Jun 24
    Reported Aug 8
    		$0.28$0.23+21.74%Beat+47.4%
    Mar 24
    Reported May 16
    		$0.25$0.20+25.00%Beat+25.0%
    Dec 23
    Reported Feb 8
    		$0.29$0.24+20.83%Beat+31.8%
    Sep 23
    Reported Nov 9
    		$0.22$0.18+22.22%Beat+29.4%
    Jun 23
    Reported Aug 8
    		$0.19$0.15+26.67%Beat+35.7%
    Mar 23
    Reported May 16
    		$0.20$0.17+17.65%Beat-4.8%
    Dec 22
    Reported Feb 9
    		$0.22$0.17+29.41%Beat-24.1%
    Sep 22
    Reported Nov 10
    		$0.17$0.16+6.25%Beat-10.5%
    Jun 22
    Reported Aug 4
    		$0.14$0.11+27.27%Beat+27.3%
    Mar 22
    Reported May 17
    		$0.21$0.15+40.00%Beat+250.0%
    Dec 21
    Reported Feb 8
    		$0.29$0.12+141.67%Beat+428.4%
    Sep 21
    Reported Nov 9
    		$0.19$0.09+111.11%Beat-56.7%
    Jun 21
    Reported Aug 10
    		$0.11$0.08+37.50%Beat+133.0%
    Mar 21
    Reported Jun 25
    		$0.06$0.00N/ABeat-
    Dec 20
    Reported Mar 31
    		$-0.09$0.00N/AMiss-
    Sep 20
    Reported Dec 31
    		$0.44$0.00N/ABeat-
    Dec 19
    Reported Mar 30
    		$-0.33$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio24.04EV/EBITDA22.53x
    Price/FCF19.36xFCF Yield5.17%
    Profitability
    Profit Margin25.50%Operating Margin21.50%
    ROE17.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio6.08xQuick Ratio6.08x
    Trading Statistics
    Beta1.22Avg Volume3.23M
    52-Week High$71.3752-Week Low$17.15

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$29.44
    SMA 20$28.12
    SMA 50$26.57
    SMA 200$26.15
    EMA 10$29.64
    EMA 20$28.54
    EMA 50$26.67
    EMA 200$29.58

    MACD

    Line: 1.32Signal: 1.04Hist: 0.28

    ADX

    ADX: 38.9+DI: 29.5-DI: 11.2

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$27.24

    Bollinger Bands

    Upper Band$31.64
    Lower Band$24.60
    %B Position2506%(Upper)
    Band Width0.98

    RSI (14-Day)

    Overbought
    70.3

    Momentum Oscillators

    Stoch %K88.7
    Stoch %D90.0
    Williams %R-0.7
    ROC (10d)10.5%
    Momentum3.00
    CCI (20d)134.0
    MFI (14d)73.1

    Volatility Measures

    ATR (14d)$1.24(3.9%)
    StdDev (20d)1.76
    Hist Vol44.9%(High)

    Volume Flow

    VWAP$30.89
    OBV-56.6M
    AD Line-72.9M
    CMF (20d)0.052

    Volume Metrics

    Avg Vol (20d)3.3M
    Vol Ratio0.9x
    VWMA (20d)$28.20

    Pivot Points

    R3$32.26
    R2$31.70
    R1$30.81
    Pivot Point$30.24
    S1$29.35
    S2$28.79
    S3$27.90

    Advanced Oscillators

    TSI30.25
    Ultimate Osc62.0
    KST125.97

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$156.62M$145.37M$185.05M$168.53M$145.91M$138.29M$168.60M$136.83M$126.68M$118.06M$135.28M$113.61M
    Cost of Revenue$23.69M$19.41M$18.70M$16.43M$15.79M$14.47M$14.18M$13.68M$13.55M$12.57M$12.19M$12.76M
    Gross Profit$132.93M$125.97M$166.35M$152.10M$130.12M$123.82M$154.42M$123.16M$113.13M$105.49M$123.09M$100.85M
    Operating Expenses$99.28M$101.14M$94.46M$88.42M$75.60M$75.14M$74.50M$70.01M$67.07M$63.64M$64.54M$67.06M
    R&D$38.48M$39.11M$34.59M$30.20M$26.80M$24.80M$22.42M$23.24M$22.57M$20.15M$19.95M$19.96M
    SG&A$15.76M$16.12M$17.66M$19.05M$12.44M$12.73M$13.59M$10.10M$9.26M$9.97M$9.64M$8.97M
    Operating Income$33.64M$24.83M$71.90M$63.68M$54.52M$48.68M$79.92M$53.14M$46.05M$41.85M$58.55M$33.79M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$40.36M$32.12M$80.80M$72.94M$64.15M$58.39M$89.84M$62.17M$53.17M$47.95M$63.03M$39.70M
    Income Tax Expense$16.05M$13.01M$19.24M$10.88M$10.83M$-4,064,000$14.64M$18.02M$11.79M$7.33M$15.08M$9.09M
    Net Income$24.32M$19.11M$61.56M$62.06M$53.32M$62.46M$75.20M$44.15M$41.38M$40.62M$47.96M$30.60M
    EBITDA$48.38M$32.03M$85.52M$77.08M$68.35M$52.01M$90.91M$63.81M$56.10M$45.23M$60.92M$36.96M
    EBIT$40.36M$24.83M$80.80M$72.94M$64.15M$48.68M$89.84M$62.17M$53.17M$41.85M$58.55M$33.79M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DOCS

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    8
    New Awards (TTM)
    2
    Avg Remaining Term
    6.0 mo

    Recent Awards

    Award IDAgencyObligatedStart
    36C26226P1144Department of Veterans AffairsDepartment of Veterans Affairs$45000Jun 15, 2026
    36C26026P0180Department of Veterans AffairsDepartment of Veterans Affairs$20000Jan 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

    SueWallSt has filed a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who purchased common stock between August 8, 2024, and May 13...

    PR Newswire•10/15/26•Bearish

    DOCS Stockholders Have Rights - If you Lost Money Investing in Doximity, Inc. Contact Robbins LLP for Information About Recovering Your Losses

    Robbins LLP is reminding investors that a class action lawsuit has been filed against Doximity, Inc. (NYSE: DOCS). The lawsuit alleges that Doximity failed to disclose its loss of market share to competitors with more...

    PR Newswire•10/14/26•Bearish

    DOCS DEADLINE: Levi & Korsinsky Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline

    Levi & Korsinsky, LLP has alerted investors of Doximity, Inc. (NYSE: DOCS) about an upcoming securities class action deadline on November 16...

    Morningstar•10/14/26•Bearish

    ROSEN, REGARDED INVESTOR COUNSEL, Encourages Doximity, Inc.

    The Rosen Law Firm is encouraging investors of Doximity, Inc. (NYSE: DOCS) to join a securities class action lawsuit before the November 16, 2026...

    GlobeNewswire•10/14/26•Bearish

    DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law

    Schall, Brown & Schwartz LLP ("SBS") has announced a class action lawsuit against Doximity, Inc. (NYSE: DOCS) for alleged securities fraud, covering the period from August 8, 2024, to May 13...

    Morningstar•10/14/26•Bearish

    DOCS Valuation and Fair Value

    P/E
    24.0x
    Forward P/E
    19.8x
    EV/EBITDA
    22.5x
    P/FCF
    19.4x
    PEG
    0.6x
    P/B
    6.3x
    See GNG's fair value

    DOCS Profitability: Margins, ROIC and FCF

    Gross margin
    88.1%
    Operating margin
    21.5%
    Net margin
    25.5%
    ROE
    17.2%
    FCF margin
    45.3%
    FCF yield
    5.2%

    DOCS Competitors

    CompanyTicker
    CG Oncology, Inc. Common stockCGON
    RadNet IncRDNT
    Haemonetics CorporationHAE
    Stevanato Group SpASTVN
    Kodiak Sciences IncKOD
    Teleflex IncorporatedTFX
    Immunovant IncIMVT
    Merit Medical Systems IncMMSI

    Sector: Healthcare

    DOCS Analyst Ratings

    Consensus
    Hold
    Analysts
    21
    Strong Buy
    5
    Buy
    3
    Hold
    11
    Sell
    1
    Strong Sell
    1

    DOCS Bull Case vs Bear Case

    Bull case

    • DOCS converts 45.3% of revenue into free cash flow.
    • DOCS has a 25.5% net profit margin.
    • DOCS beat EPS estimates in 75.0% of its last 8 reported quarters.

    DOCS Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    15.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.35
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 13 down

    Frequently Asked Questions About DOCS

    Does DOCS pay dividends?

    Doximity Inc (DOCS) does not currently pay a regular dividend.

    What is DOCS's P/E ratio?

    Doximity Inc has a price-to-earnings (P/E) ratio of 24.04.

    What is DOCS's market cap?

    Doximity Inc (DOCS) has a market capitalization of $5.45B with a current stock price of $31.50.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In